- Vishay Intertechnology 2Q EPS 19c >VSH
- Regal Rexnord Narrows 2026 View To Adj EPS $10.35-Adj EPS $10.85 >RRX
- Regal Rexnord Narrows 2026 View To EPS $5.42-EPS $5.92 >RRX
- Regal Rexnord 2Q Adj EPS $2.99 >RRX
- Pyxus International 1Q Rev $437.8M >PYYX
- The spot premium of Middle Eastern benchmark crude oil has declined, as the expected reopening of the Hormuz Strait signals an easing of supply constraints.
- Uber shares slipped over 3% in premarket trading; total gross bookings for the second quarter reached $58.02 billion, surpassing the market expectation of $57.17 billion; the company expects total gross bookings for the third quarter to be between $58.25 billion and $60.25 billion, while the market anticipated $59.32 billion.
- Seres Therapeutics 2Q Research and Development Expenses $9.1M >MCRB
- Valvoline Adjusts 2026 View To Adj EPS $1.70-Adj EPS $1.75 >VVV
- Entrada Therapeutics 2Q Rev $898,000 >TRDA
- Valvoline Adjusts 2026 View To Rev $2.05B-$2.1B >VVV
- Entrada Therapeutics 2Q Loss/Shr $1.01 >TRDA
- Valvoline Raises 2026 System-wide SSS Growth to 7.5%-8% >VVV
- U.S. Tech Stocks Stage Major Comeback! Earnings Season Rekindles AI Faith, Nasdaq 100 Market Cap Surges $3.5 Trillion in Four Days
- Circle names BlackRock, Visa as initial partners for Arc blockchain
- Correct: Charles River Labs Sees FY26 EPS $3.05-EPS $3.35 >CRL
- Kyndryl Reaffirms FY27 Outlook for Revenue, Earnings and Free Cash Flow >KD
- Kyndryl 1Q Rev $3.6B >KD
- Kyndryl 1Q Loss/Shr 25c >KD
- Lifecore Biomedical 2Q Rev $34.2M >LFCR
- Charles River Labs Sees 3Q EPS $3.05-EPS $3.35 >CRL
- Royalty Pharma Raises 2026 Portfolio Receipts View to $3.4B-$3.5B >RPRX
- Lifecore Biomedical 2Q Adjusted EBITDA $8.6M >LFCR
- Charles River Labs Sees FY26 Adj EPS $11.15-Adj EPS $11.45 >CRL
- Crypto Finance Company BIT Predicts Gold and Bitcoin Will Rise Together! Here Are the Details
- TRON’s 15 billion milestone meets fading buy pressure – Can TRX’s $0.332 fall?
- Expert to XRP & Crypto Traders: This Is the Signal We’ve Been Waiting for
- VersaBank Says SEC's Declaration is Final Requisite Step Prior to Shareholder Meeting on Sept 16
- J&J Snack Foods 3Q Adj EPS $1.96 >JJSF
- Japanese Finance Minister: Viscent thinks Japan's fiscal discipline is improving and denies U.S. pressure
- Today's Bullish Patterns & Technical Sentiment | Published on 08/04: GRND, ZTO, ATLC and More
- US Bank Groups Warn GENIUS Act Rules Could Create Stablecoin Compliance Gaps
- GlobalFoundries 2Q EPS 30c >GFS
- GlobalFoundries 2Q Rev $1.79B >GFS
- Brink's Co 2Q Adj EPS $2.13 >BCO
- Shopify 2Q Rev $3.58B >SHOP
- GlobalFoundries Sees 3Q Rev $1.89B >GFS
- Astec Industries 2Q EPS 45c >ASTE
- Shake Shack 2Q Net $15.7M >SHAK
- US MBA Mortgage Survey Snapshot
- SharkNinja Says First AI-Developed Products to Launch in 4Q >SN
- SharkNinja Expects AI To Shape Most Product Innovation by 2027, CEO Says >SN
- Q32 Bio 2Q Loss/Shr 44c >QTTB
- Eli Lilly shares surged more than 5% in pre-market trading; second-quarter revenue reached $22.974 billions, up 48% year-on-year; adjusted earnings per share stood at $8.38, marking a 33% year-on-year increase.
- German 10-year government bond yields hit a three-week low as expectations of a Hormuz Strait agreement weighed on oil prices and rate hike bets.
- Spot platinum has just broken through the $1,740.00/oz mark, currently quoted at $1,739.98/oz, up 0.41% on the day; Nymex main platinum futures are currently quoted at $1,757.2/oz, up 0.07% on the day.
- Hagerty 2Q Loss/Shr 2c >HGTY
- Uber Technologies 2Q EPS $1.17 >UBER
- Uber Technologies 2Q Monthly Active Platform Consumers Up 16% >UBER
- Uber Technologies 2Q Gross Bookings Up 24% >UBER
- Uber Technologies 2Q Gross Bookings $58B >UBER
- Uber Technologies 2Q Freight Gross Bookings $1.57B >UBER
- Uber Technologies 2Q Freight Gross Bookings Up 25% >UBER
- Uber Technologies 2Q Adj EPS 81c >UBER
- Uber Technologies 2Q Rev $14.19B >UBER
- Uber Technologies 2Q Gross Bookings $58.02B >UBER
- Uber Technologies 2Q Freight Gross Bookings $1.57B >UBER
- Uber Technologies 2Q Gross Bookings Up 24% >UBER
- Uber Technologies 2Q Trips 3.87B >UBER
- Uber Technologies 2Q Gross Bookings Up 22% on Constant-Currency Basis >UBER
- Uber Technologies 2Q Adjusted Ebitda $2.8B >UBER
- Uber Technologies: Added More First-Time Users in Past 12 Months Than in Any Period Over Past Five Years >UBER
- Uber Technologies: 3Q Gross Bookings Outlook Assumes Roughly 1 Percentage-Point Currency Headwind to Total Reported YoY Growth >UBER
- Uber Technologies 3Q Adj EPS Outlook Translates to Adj Ebitda of $2.86B-$2.96B >UBER
- Uber Technologies 2Q EPS $1.17 >UBER
- Uber Technologies 2Q Delivery Gross Bookings $27.46B >UBER
- Uber Technologies 2Q Monthly Active Platform Consumers 208M >UBER
- Uber Technologies 2Q Monthly Active Platform Consumers Up 16% >UBER
- Uber Technologies 2Q Net Cash Provided by Operating Activities $2.9B, Free Cash Flow $2.8B >UBER
- Uber Technologies 2Q Adjusted Ebitda Margin 4.9% of Gross Bookings >UBER
- Uber Technologies 2Q-End Unrestricted Cash, Cash Equivalents and Short-Term Investments $5.4B >UBER
- Uber Technologies: AVs Are Live on Uber in 7 Cities, on Track for as Many as 15 by Year End >UBER
- Uber Technologies Sees 3Q Gross Bookings $58.25B-$60.25B >UBER
- Uber Technologies Sees 3Q Adj EPS $84-Adj EPS 88c >UBER
- Uber Technologies 2Q Mobility Gross Bookings $28.99B >UBER
- Uber Technologies 2Q Net $2.4B >UBER
- Uber Technologies 2Q Rev $14.2B >UBER
- Disney (DIS.US): Still predicts full-year capital expenditure of $9 billion (market estimate: $8.88 billion).
- Bitcoin ETFs log inflows as cold wallet hack reignites custody debate
- Eli Lilly Adjusts FY View To Adj EPS $35.50-Adj EPS $36.50 >LLY
- Eli Lilly 2Q Revenue Outside the U.S. Increased 80% to $8.6 B >LLY
- Eli Lilly Raises FY View To Rev $85B-$87B >LLY
- Eos Energy Enterprises 2Q Loss $406.3M >EOSE
- Materion 2Q Net $38.8M >MTRN
- Materion 2Q Sales $613.9M >MTRN
- Materion 2Q EPS $1.84 >MTRN
- Materion Sees FY Adj EPS $6.80-Adj EPS $7.20 >MTRN
- Eos Energy Enterprises 2Q Loss/Shr $1.20 >EOSE
- Eos Energy Enterprises 2Q Rev $68.8M >EOSE
- Iron Mountain 2Q Net $101.4M >IRM
- Iron Mountain 2Q FFO 76c/Shr >IRM
- Chimera Investment 2Q Loss/Shr 5c >CIM
- Chimera Investment 2Q Adj EPS 46c >CIM
- Eli Lilly Sees FY Rev $85B-$87B >LLY
- Eli Lilly 2Q EPS $7.94 >LLY
- Eli Lilly 2Q Adj EPS $8.38 >LLY
- Eli Lilly 2Q Net $7.1B >LLY
- Eli Lilly 2Q Rev $22.97B >LLY
- Eli Lilly 2Q Zepbound Rev $4.93B >LLY
- Iron Mountain 2Q EPS 34c >IRM
